Professor, Medicine, University of Toledo College of Medicine
Rheumatology
Dr. M B. Kahaleh, MD
|
|
Give Review
M B. Kahaleh, MD practices Rheumatology. He received 1 awards: "Meaningful Use Stage 1 Certification". Kahaleh is also published. He has 37 publications published. The lastest publication: "Effect of cytokines on the production of endothelin by endothelial cells.' Kahaleh is registered with Medicare and accepts Medicare payments.
Publications
- FcγRIIa Ligation Induces Platelet Hypersensitivity to Thrombotic Stimuli.
- Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy.
- Effects of cardiotonic steroids on dermal collagen synthesis and wound healing.
- Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy.
- Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
- Raynaud phenomenon and the vascular Disease in scleroderma.
- Reproducible gene expression measurement among multiple laboratories obtained in a blinded study using standardized RT (StaRT)-PCR.
- Initial evidence of endothelial cell apoptosis as a mechanism of systemic capillary leak Syndrome.
- Gammadelta receptor bearing T Cells in scleroderma: enhanced interaction with vascular endothelial Cells in vitro.
- Mechanism of serum-mediated endothelial injury in scleroderma: identification of a granular enzyme in scleroderma skin and sera.
- Raynaud's phenomenon and the vascular Disease in scleroderma.
- The role of vascular endothelium in the pathogenesis of connective tissue Disease: endothelial injury, activation, participation and response.
- A modified scleroderma skin scoring method.
- A fibroblast mitogen present in scleroderma but not control sera: inhibition by proteinase inhibitors.
- Transitions in generalized scleroderma.
- Plasmapheresis and immunosuppressive drug therapy in scleroderma.
- Vascular involvement in systemic sclerosis (SSc).
- Enhanced platelet adhesion to collagen in scleroderma. Effect of scleroderma plasma and scleroderma platelets.
- Effect of scleroderma serum on human fibroblast collagen production: possible selection through proliferation.
- Soluble immunologic products in scleroderma sera.
- Effect of lymphotoxin and tumor necrosis factor on endothelial and connective tissue Cell growth and function.
- Mast Cell changes in scleroderma. Presence of MCT Cells in the skin and evidence of mast Cell activation.
- Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and Disease duration.
- Endothelial injury in scleroderma.
- Autoimmunity and vascular involvement in systemic sclerosis (SSc).
- Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred.
- Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
- Vascular Disease in scleroderma. Endothelial T lymphocyte-fibroblast interactions.
- Endothelial injury in scleroderma. A protease mechanism.
- Effect of cytokines on the production of endothelin by endothelial Cells.
- The role of vascular endothelium in fibroblast activation and tissue fibrosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hype...
- Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action.
- Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: possible role for IL-6.
- The vascular endothelium in scleroderma.
- Human monocyte modulation of endothelial Cells and fibroblast growth: possible mechanism for fibrosis.
- Raynaud's phenomenon and vascular Disease in scleroderma.
Schools
University Of Damascus Faculty Of Medicine
Huron Road Hospital
Ohio Mc Hosps
Med University Sc Hosps
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Non-Spinal Nerve Blocks
- Steroid Injection
- View All
Conditions Treated
- Amyloidosis
- Ankylosing Spondylitis
- Arthritis
- Behçet's Disease
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Damascus University Faculty of Medicine
Drug Facts
| NPI NUMBER | 1891781050 | |
| NPPES Provider LastName | KAHALEH | |
| NPPES Provider FirstName | M | |
| NPPES Provider ZIPCode | 436145811 | |
| NPPES Provider State | OH | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 2651.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 250.0 | |
| Percent Opioid Claims | 9.43 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891781050 |
| Last Name Of The Provider | KAHALEH |
| First Name Of The Provider | M |
| View All |
Similar Doctors
|
|
Dr. Allan B. Kirsner, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward Goldberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abigail R. Smukler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheryl F. Mascarenhas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammed A. Abusamieh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen J. Farber, MD
This Doctor is OpenDoctor Recommended.
|